Sign Up
Stories
AVITA Medical Revenue Revision Impact
Share
EIC Fund Supports European Deeptech Star...
EIC Fund Supports European Deeptech Star...
EIC Fund: Backing Deeptech Startups with...
A Flurry of Activity in the European Tec...
Alantra Advises Nimble Approach on SCC I...
Bonduelle's Fiscal Performance Analysis
Overview
API
AVITA Medical revised Q1 2024 revenue to $11.0-11.3 million due to slow account conversions, affirming full-year outlook at $78.5-84.5 million. The company added 73 new accounts with 22 in Q1 2024, emphasizing growth strategies and product launches.
Ask a question
How could market dynamics in regenerative medicine affect AVITA Medical's future performance?
How might AVITA Medical accelerate account conversions to meet revenue targets?
What innovative products are expected from AVITA Medical's upcoming launches?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage